 Orgenesis Inc NASDAQ:ORGS FRA:45O announced Monday it has signed a collaboration agreement with Dong-a University Hospital in South Korea and Cure Therapeutics Inc to utilize Orgenesis Mobile Processing Units and Labs OMPULs. The company said the teams will align to use the OMPULs for point-of-care development of cell and gene therapies and immunotherapies that meet regulatory and governmental approval standards to scale through to commercialization. 